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Abstract
Metabolic depletion of hereditary ovalocytes leads, similar to normal red cells, to decreased intracellular concentrations
of ATP and GSH as well as degradation of the phosphoinositides to phosphatidylinositol and diacylglycerol. In contrast to
normal red cells, however, loss of ATP does not induce any gross shape transformations; even after extensive depletion the
ovalocytes retain their initial elongated stomatocytic character. The mechanical properties of hereditary ovalocytes are
associated with a deletion of nine amino acid residues in band 3. Since the deletion appears to increase the stiffness of a
normally flexible region of band 3, connecting the N-terminal cytoplasmic domain with the membrane spanning domain,
our results indicate that shape changes require a flexible attachment of the cytoskeleton to the membrane-spanning band 3.
The results also imply that metabolism of phosphoinositide cannot be the only determinant of cell shape, as suggested by
the bilayer-couple hypothesis, but also other factors are involved in metabolically induced shape transformations.
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1. Introduction
When the red blood cell travels around the vascu-
lar system the cell has to withstand not only consider-
ably mechanical stress caused by turbulence in the
heart but also the shearing forces in the thin capillar-
ies. The remarkable ability to passively change shape
without disruption allows the red cell to survive the
ferocious environment. This essential quality requires
the membrane to be deformable, elastic and stable.
The membrane cytoskeleton, which lines the cyto-
plasmic surface of the red cell membrane, and the
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membrane lipid bilayer are believed to be responsible
for the mechanical properties and elasticity of the red
w xcell 1–3 . Mutations, deletions or loss of cytoskeletal
proteins result in impaired protein–protein associa-
tions and lead to anomalies in rigidity, cell shape and
w xreduced stability of the membrane 4,5 .
South East Asian ovalocytes are oval-shaped ery-
throcytes that are more rigid and less deformable than
w xordinary red cells 6–9 . The anomaly of hereditary
ovalocytes is associated with the deletion of nine
amino acids, from residue 400 to 408, at the bound-
ary between the N-terminal cytoplasmic and mem-
brane domains, in about 40% of the band 3 molecules
w xpresent in ovalocytic membranes 10–12 . It is likely
that the homozygous state is lethal as no homozygous
individual is known. Since red cells of heterozygotes
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 .PII S0005-2736 97 00037-0
( )J. Bjork et al.rBiochimica et Biophysica Acta 1326 1997 342–348¨ 343
are less vulnerable to malaria invasion in vitro, it has
been suggested that hereditary ovalocytosis confer
w xsome protection against malaria 13,14 . However,
more recent data indicate that fresh ovalocytes are
invaded by the parasite nearly as well as normal red
w xcells 15 . The deletion mutation is linked to a point
 .mutation at amino acid 56 Lys to Glu , which also
occurs in a common asymptomatic band 3 variant
w xknown as band 3 Memphis 16–18 .
When a normal red blood cell is depleted of its
ATP, a series of shape changes occur. At the early
stages, bumps appear on the cell membrane. Later
these bumps change into spicules and the discoid
character is lost in favour of a spherical form. If the
process is allowed to continue, the spicules are elon-
gated and, in due course, lost as microvesicles with
the formation of a smooth spherical cell. The shape
changes can be reverted up to the point of membrane
w xloss by allowing the cell to synthesize ATP 19–21 .
Metabolic depletion under many different conditions
have shown that the shape transformation parallels
the dephosphorylation of phosphatidylinositol 4,5-
 .bisphosphate PIP , phosphatidylinositol 4-mono-2
 .  . w xphosphate PIP and phosphatidic acid PA 22,23 .
Since these phospholipids are localized mainly to the
w xinner leaflet of the membrane 24 , dephosphorylation
of the phosphoinositides would reduce the area of
that leaflet, forcing the outer leaflet to produce the
protrusions characteristic of echinocytosis. This be-
haviour is in accordance with the bilayer-couple hy-
pothesis that explains the cell shape as a function of
the relative areas of the inner and outer leaflets of the
w xmembrane 25,26 .
Although the shape change behaviour of hereditary
ovalocytes has not been studied previously, it seemed
likely that metabolic depletion of these abnormally
rigid cells might lead to different shape transforma-
tions. Assuming that the bilayer-couple hypothesis is
correct, it follows that the dephosphorylation of phos-
phoinositides in ovalocytes during depleting condi-
tions should also be impaired.
In this study we have investigated the effect of
metabolic depletion on the shape and phosphoinosi-
tide metabolism of hereditary ovalocytes. We found
that shape changes occurred in hereditary ovalocytes,
though to a much lesser extent than in normal cells,
and that the metabolism of the phosphoinositides was
very similar to that observed in normal red cells.
2. Materials and methods
Fresh human blood was kindly provided by the
blood bank at the University Hospital, Umea. The˚
clinical and laboratory details of the donor of the
ovalocytes and his identical twin brother have been
w xreported previously 27 . Briefly, the donor presented
with clinical symptoms associated with a well-com-
pensated, mild hemolysis. The characteristic red cell
morphology, protein and DNA abnormalities of band
3 in South East Asian ovalocytosis were detected in
both cases. A similar clinical history was recounted
for paternal relatives. Normal red cells were drawn at
the same time and, exactly as the ovalocytes, trans-
ported from England to Sweden. Due to the trans-
portation 4 days elapsed before the start of the exper-
iments. Therefore these normal red cells were termed
‘old’ control cells. Essentially fatty acid-free bovine
 .serum albumin BSA and glutaraldehyde were from
Sigma. Penicillin G-streptomycin mixture was from
w32 xGibco. Carrier-free P Orthophosphate was pur-
chased from Amersham. Silica gel 60 thin-layer chro-
 .matography plates 20 cm=20 cm were from Merck.
All other chemicals were of at least reagent grade.
Red cells were washed five times with ice-cold
buffer H 130 mM NaCl, 3.7 mM KCl, 2 mM
.MgCl , 1 mM EGTA, 25 mM Hepes, pH 7.5 and2
twice with ice-cold complete buffer H buffer H
containing 100 units mly1 penicillin G, 100 units
y1 y1 .ml streptomycin and 1 mg ml BSA . Plasma and
buffy coat were removed by aspiration after each
centrifugation.
 .Red cells 10% haematocrit were labelled with
w32 x  y1.P orthophosphate 0.74 MBq ml by incubation
for 25 h at 378C in complete buffer H supplemented
with 10 mM glucose and 1 mM adenosine. After
incubation, cells were washed four times with buffer
H and twice with complete buffer H.
Metabolic depletion was initiated by resuspending
32P-labelled cells to 10% haematocrit in complete
buffer H.
Cells were fixed by mixing 30 ml of the red cell
suspension in 0.2 ml 1% glutaraldehyde in 0.1 M
 .potassium phosphate buffer pH 7.5 for 60 min at
room temperature. The morphological index was de-
termined by phase contrast microscopy, counting at
least 400 cells of each sample. Discocytes and
echinocytes were assigned a morphology score of 0
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w xand 1–4, respectively 28 and the average score of
each sample was taken as the morphological index.
For scanning electron microscopy, fixed cells were
washed in phosphate-buffered isotonic saline and 50
ml of each sample was placed onto glass coverslips
w xpre-coated with poly-L-lysine 29 . The coverslips
were gently rinsed with isotonic saline, dehydrated in
increased concentrations of ethanol and dried from
w xCO using critical point technique 30 . Coverslips2
were mounted on aluminium stubs and coated with
gold using a combined system of sputter-coating
Edwards S150A Sputter Coating Unit, Edwards High
.Vacuum and a modified vacuum coating system
equipped with an automatic rotation and tilting de-
 .vice Edwards E14 Vacuum Coating Unit . All speci-
mens were analyzed in a Leo S-360 iXP scanning
 .electron microscope Leo Electron Microscopy Ltd.
 .fitted with a LaB6 emitter Kimbal Physics Inc.
running at standard settings. Micrographs were taken
from all samples at an original magnification of 2500
and 5000 times.
ATP and GSH were determined as described pre-
w xviously 23 . The concentration of haemoglobin in
lysates was determined from measurements of ab-
sorbance at 539 nm using a molar absorbtivity of
3 y1 y1 w x13.4=10 M cm per haem 31 .
Lipids were extracted from frozen samples of cell
suspension using acidic methanolrchloroform and
separated by thin-layer chromatography as described
w xbefore 23 . Radiolabelled phospholipids were de-
tected by autoradiography and quantified by liquid
scintillation counting of scraped spots. Lipid phos-
w xphorus was determined spectroscopically 32 .
3. Results
Incubation of ovalocytes, in the absence of nutri-
ents such as glucose, caused depletion of both ATP
and GSH, as shown in Fig. 1. Both hereditary ovalo-
cytes and control cells treated in exactly the same
way i.e., drawn at the same time and transported
.from England to Sweden had lower initial levels of
ATP 0.56 and 1.05 mmolerg haemoglobin, respec-
. tively and GSH 3.7 and 4.6 mmolerg haemoglobin,
.respectively even after repletion with glucose and
adenosine compared to fresh control cells 4.1 mmole
Fig. 1. ATP- and GSH-levels during metabolic depletion of
human red cells. Washed red cells were suspended at 10%
haematocrit in complete buffer H and incubated at 378C. At the
indicated times samples were withdrawn and the concentration of
 .  .ATP top and GSH bottom were determined as described in
Section 2. 100% ATP represent 0.56 mmolerg haemoglobin in
 .ovalocytic red cells B and 1.05 mmolerg haemoglobin in ‘old’
 .control cells v . The initial concentrations of GSH were 3.7 and
 .4.6 mmolerg haemoglobin in ovalocytes B and control cells
 .v . The dotted lines represent the time course of changes in
 . ATP 4.1 mmolerg haemoglobin and GSH 7 mmolerg
.haemoglobin of fresh control cells.
Fig. 2. Time course of shape changes during metabolic depletion.
Samples were withdrawn at the indicated times and fixed by
 .glutaraldehyde. The extent of crenation of ovalocytes B and
 .‘old’ control red cells v was determined by phase contrast
 .microscopy. The shape changes of fresh red cells dotted line
were also determined.
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ATPrg haemoglobin and 7 mmole GSHrg
.haemoglobin . The lower initial level of ATP has
w xbeen observed previously 15 and can probably be
attributed to an enhanced energy consumption due to
a membrane leakage of cations in ovalocytic cells.
Even though the initial concentrations of ATP and
 .  .Fig. 3. Scanning electron microscopy of red cells. Samples of hereditary ovalocytes left column or ‘old’ control red cells right column
 .  .  .were withdrawn after 0 h top row , 1 h middle row and 13 and 7 h ovalocytes and control cells, respectively; bottom row metabolic
depletion and prepared for electron microscopy. Scale: Bar represents 5 mm in top and middle row and 10 mm in bottom row.
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GSH were lower in the ovalocytes, the relative
changes in ATP and GSH were very similar to those
 .observed both in ‘old’ i.e., transported and fresh
control red cells. Whether the slightly faster decline
in the relative ATP level of ovalocytes was a genuine
effect or due to increased membrane leakage is un-
known at present.
Independent of the pre-treatment, control cells lost
their discoid shape upon incubation under ATP-de-
pleting condition. The normal biconcave shape was
gradually lost in favour of various states of spiculated
cell shapes. Eventually, the typical spikes of
echinocytosis were shed, giving rise to a smooth
spherocyte. The ‘old’ control cells went through a
quicker echinocytosis than fresh control cells, lacking
 .the usual lag phase initially Fig. 2 . These cells
reached a morphological index of 2 after about 4–5
h, whereas fresh cells required about 10 h metabolic
depletion to reach the same stage of shape transfor-
mation.
In striking contrast to the control cells, by phase
contrast microscopy it was not possible to observe
any noticeable shape transformation of ovalocytic red
cells upon ATP-depletion; even after extensive
metabolic depletion the morphological index only
 .reached 0.2 Fig. 2 . However, when the same cells
were observed by scanning electron microscopy, it
became evident that metabolic depletion did indeed
cause substantial shape transformation, also of ovalo-
cytes, although the extent of transformation was much
less pronounced. Ovalocytes did not go through the
typical stages of echinocytosis, including loss of bi-
concave shape and development of protrusion and
spikes on the membrane surface. Instead these cells
developed an undulated pattern of bumps or bulges
on the membrane surface, as shown by Fig. 3. Even
 .after extensive depletion i.e., in the absence of ATP
the ovalocytes retained the stomatocytic character.
The lack of any major shape changes in ovalocytes
seemed to indicate, when interpreted in accordance
with the bilayer-couple hypothesis, that the relative
areas of the outer and inner leaflet of the membrane
did not change upon metabolic depletion. Since
degradation of the phosphoinositides are believed to
be the major cause of area change of the two leaflets
w xduring depletion 22,23 , our results imply that the
phosphoinositide metabolism of ovalocytic red cells
differs from normal red cells. To investigate this
Fig. 4. Metabolism of the phosphoinositides during metabolic
depletion. Labelled red cells were incubated at 378C in the
absence of nutrients to induce depletion. Samples were with-
drawn and analyzed as described in Section 2, and the fractions
 .of PIP , PIP and PA from ovalocytes B , ‘old’ control cells2
 .  .v , and fresh control cells dotted line were determined.
possibility, ovalocytes were labelled by preincubation
for 24 h with nutrients and radioactive orthophos-
phate, a treatment that incorporates the label into
PIP , PIP and PA as well as several proteins2
w x22,23,33,34 . As expected, among the phospholipids
only PIP , PIP and PA were labelled.2
In spite of the atypical shape changes, the phos-
phoinositide turn-over of the ovalocytes did not differ
significantly from that of the ‘old’ control cells Fig.
.4 . However, the phosphoinositide metabolism was
not as extensive as in fresh control cells; the final
fraction of labelled PIP was higher and that of2
labelled PA was lower in both ovalocytes and ‘old’
control cells compared to fresh control cells. This less
extensive phosphoinositide turnover can most proba-
bly be attributed to the ‘ageing’ process of the cells
during transportation, which reduced the energy level
as well as the reduction potential of the cell.
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4. Discussion
Similar to normal red cells, hereditary ovalocytic
red cells change their shape upon metabolic deple-
tion. However, in contrast to normal cells, the shape
transformations are not very extensive; the ovalocytes
retain their elongated stomatocytic character through-
out depletion and only develop bulges on the mem-
brane surface. This shape change behaviour indicates
that ovalocytes go through shape transformations dif-
ferent from normal red cells and that it is unlikely
that normal echinocytosis is balanced by the initial
stomatocytic shape of the ovalocytes.
Based on the bilayer-couple hypothesis, it has been
suggested that metabolically induced shape changes
are correlated with the phosphoinositide metabolism
and, in the case of echinocytosis, reduction of the
w xarea of the inner leaflet of the membrane 22,23 .
Therefore it was surprising that the phosphoinositide
metabolism of ovalocytes was very similar if not
.identical to that of normal cells. At the same time,
this observation suggests that the phosphoinositide
distribution between the two leaflets should be simi-
lar in these cells. If correct, it follows that the effect
of degradation of PIP , PIP and PA to phosphatidyl-2
inositol and diacylglycerol, which should reduce the
area of the inner leaflet to the same extent in ovalo-
cytes as in normal cells, somehow is counteracted in
the ovalocytes.
Hereditary ovalocytes are extremely rigid with a
shear elastic modulus nearly four times that of nor-
w xmal red cells 7,8,12 . The rigidity is associated with
the deletion of nine amino acids located between the
N-terminal cytoplasmic and membrane domains,
deleting a flexible hinge connecting these domains
w x35 . The structure of the membrane spanning do-
mains of mutated band 3 is altered and the anion
transport activity as well as the translational diffusion
w xin the membrane are reduced 12,36,37 . In contrast,
the N-terminal cytoplasmic domain appears not to be
affected as mutated band 3 binds ankyrin with normal
w xcapacity and affinity 12,37 .
Therefore it is likely that the abnormal mechanical
properties of ovalocytic red cells are related to the
increased stiffness of a normally flexible region of
band 3. Exactly how is not known; it is possible that
the translational constraints of mutated band 3 hinder
normal movement of band 3-bound ankyrin required
when the cell undergoes local deformation, as sug-
w xgested by Schofield et al. 12 . Interestingly, mutated
band 3 appears to have an increased propensity to
aggregate and these oligomers are enriched in longi-
w xtudinal strands of intramembrane particles 9,38 ,
 .thereby preventing extension and contraction of the
cytoskeleton and, thus, also cell deformation. In addi-
tion, the mutation may cause an entanglement of the
w xband 3 with the cytoskeleton 11 . An impeded mobil-
ity of mutated band 3, whether through oligomer
formation or interactions with the lipid bilayer or
cytoskeleton, will obviously restrict the distortion that
the cytoskeleton must undergo when the cell is de-
formed.
Upon metabolic depletion and concomitant degra-
dation of the phosphoinositides, the area of the inner
leaflet of the bilayer should shrink. However, the
reduced area of the inner leaflet must be accompa-
nied by a similar contraction of the cytoskeleton.
Therefore it is possible that a cytoskeleton with a
 .highly reduced ability to contract or expand would
 .inhibit or reduce the loss of inner leaflet area.
Consequently, such a cell would not be able to
change its shape.
Since the turnover of the phosphoinositides in
ovalocytes does not differ from that of normal red
cells, it is evident that shape transformations of the
red cell cannot be explained solely by the bilayer-
couple hypothesis. Our results indicate that a fully
flexible cytoskeleton is required for normal shape
changes to occur, at least when induced metaboli-
cally.
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